Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2012
10/24/2012CN102746259A Labdane diterpenoid compounds, arborvitae seed extract, preparation method thereof and application thereof
10/24/2012CN102746214A Novel indoline compounds
10/24/2012CN102746213A Cinnamamide histone deacetylase inhibitor, preparation method thereof, and application thereof
10/24/2012CN102744136A Preparation method for nanometre pearl powder
10/24/2012CN102743769A Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation
10/24/2012CN102743744A Applications of alliinase, and medicinal composition
10/24/2012CN102743740A Compositions for nasal delivery
10/24/2012CN102743734A Application of Tianlou Guizhi decoction in treatment of post-stroke spasm
10/24/2012CN102743713A Drug rehabilitation traditional Chinese medicine and its preparation method
10/24/2012CN102743709A Traditional Chinese medicine preparation for treating wind-evil invasion supraorbital neuralgia and preparation method thereof
10/24/2012CN102743706A Externally applied traditional Chinese medicine ointment for treating hemicrania
10/24/2012CN102743699A Traditional Chinese medicine for treating mental diseases
10/24/2012CN102743671A Chinese medicine composition for treating cerebral concussion sequela
10/24/2012CN102743644A Decoction medicament for treating heart-fire hyperactivity type insomnia
10/24/2012CN102743582A Traditional Chinese medicine wine
10/24/2012CN102743523A Production process of traditional Chinese medicine for treating anhypnia
10/24/2012CN102743499A Chinese medicinal herb drug for treating soft tissue internal injury blood stasis and cerebral hemorrhage
10/24/2012CN102743494A Application of rehmanniae potion to preparation of medicament for promoting spinal cord injury restoration
10/24/2012CN102743468A Traditional Chinese medicine preparation for treating headache, dizziness and concussion sequelae
10/24/2012CN102743461A Traditional Chinese medicine composition capable of harmonizing stomach and soothing the nerves and preparing method and application thereof
10/24/2012CN102743456A Use of traditional Chinese medicine composition in preparation of drug for preventing and treating delayed encephalopathy after acute carbon monoxide poisoning
10/24/2012CN102743419A Preparation method and application of liquidambar formosana hance fruit total tannins extract
10/24/2012CN102743418A Seabuckthorn fruit oil powder and preparation method thereof
10/24/2012CN102743408A Application of Cistanche deserticola polysaccharide in medicine preparation used for improving learning memory function
10/24/2012CN102743401A Application of panaxadiol saponins fraction in preparing medicine for preventing epilepsia
10/24/2012CN102743385A Modulators of atp-binding cassette-transporters
10/24/2012CN102743382A Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
10/24/2012CN102743368A Compounds for the treatment of metabolic disorders
10/24/2012CN102743367A Application of liquidambar formosana hance fruit tannin monomer
10/24/2012CN102743365A Use of compound or its pharmaceutically acceptable salt in prevention and treatment on senile dementia
10/24/2012CN102743364A Application of metformin in preparations of drugs for treatment of Parkinson's disease
10/24/2012CN102743357A Pregabalin sustained release preparation effervescent and floating in stomach and preparation method thereof
10/24/2012CN102743355A Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
10/24/2012CN102743340A Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate
10/24/2012CN102743333A Levetiracetam oral liquid and preparation method of levetiracetam oral liquid
10/24/2012CN102138982B Compound valeriana amurensis composition for treating senile dementia, and preparation method and application thereof
10/24/2012CN102099033B Pharmaceutical composition for treatment of fibromyalgia
10/24/2012CN102091056B Cell microcapsule for treating parkinsonism and composite cytoskeleton
10/24/2012CN101957346B Novel method for studying medicament metabolism by using model organism zebrafish
10/24/2012CN101855228B Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors
10/24/2012CN101827839B 1,3,5-trisubstituted triazole derivative
10/24/2012CN101766690B Multipurpose utilization method for improving the value of schisandra chinensis medicinal material
10/24/2012CN101754758B A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
10/24/2012CN101744852B Preparation method of acanthopanax effervescent tablet and products thereof
10/24/2012CN101511388B Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders
10/24/2012CN101254306B Drug containing adhesive preparation
10/24/2012CN101208344B (R)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use
10/23/2012US8293903 3-aminocyclopentanecarboxamides as chemokine receptor agonists
10/23/2012US8293765 Injectable depot formulation comprising crystals of iloperidone
10/23/2012US8293758 Substituted spirocyclic cyclohexane derivatives
10/23/2012US8293755 Treatment of statin side effects using uridine derivatives
10/23/2012US8293754 Thienopyrimidine derivatives
10/23/2012US8293730 Substituted imidazo[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives
10/23/2012US8293273 Controlled release and taste masking oral pharmaceutical composition
10/23/2012US8293269 Compositions for promoting sleep
10/23/2012US8293268 Local administration of gallium compositions to treat pain
10/23/2012US8293223 Treatment of organ injuries and burns using placental stem cells
10/23/2012CA2528284C Use of pyrazolopyridines for the treatment of cognitive deficits
10/23/2012CA2498022C Combination of mglur antagonists for the treatment of addictive disorders
10/23/2012CA2488635C Antagonists of melanin concentrating hormone receptor
10/23/2012CA2441410C Compounds and method of treatment having agonist-like activity selective at alpha 2b or 2b/2c adrenergic receptors
10/23/2012CA2412494C Agonist anti-trk-c monoclonal antibodies
10/18/2012WO2012142474A2 N-acetyl beta alanine methods of use
10/18/2012WO2012142388A2 Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders
10/18/2012WO2012141990A1 Parp inhibitors for the treatment of cipn
10/18/2012WO2012141553A2 Stabilizing composition for tetrahydrobiopterin, and method for analyzing tetrahydrobiopterin using same
10/18/2012WO2012141228A1 Novel pyrazole derivative
10/18/2012WO2012140894A1 Pharmaceutical composition
10/18/2012WO2012140114A1 Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent
10/18/2012WO2012139993A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012WO2012139963A1 N- cyclobutyl - imidazopyridine - methylamine as trpv1 antagonists
10/18/2012WO2012139925A1 Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
10/18/2012WO2012139876A1 Enteric formulations of metabotropic glutamate receptor modulators
10/18/2012WO2012139529A1 D-amino acid oxidase inhibitor for preventing and/or reversing opioid tolerance
10/18/2012WO2012139524A1 Cb1 receptor inhibitor with low toxicity and optical activity and preparation method and use thereof
10/18/2012WO2012139425A1 5-substituted iminothiazines and their mono-and dioxides as bace inhibitors,compositions,and their use
10/18/2012WO2012139191A1 Pharmaceutical compositions containing 11,12-pyrazole minocycline and use thereof for relieving pain of neuropathic origin
10/18/2012WO2012122334A3 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
10/18/2012WO2012114285A9 Heteroaryl derivatives as alpha7 nachr modulators
10/18/2012WO2012113850A3 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR
10/18/2012WO2012102875A3 Analgesic compounds, methods, and formulations
10/18/2012WO2012099375A3 P47phox or p67phox-targeting therapeutic agent for stress disorders, and method for screening for same
10/18/2012US20120266263 Method of treating memory disorders and enhancing memory using igf-ii compounds
10/18/2012US20120266262 Methods and compositions relating to zpa polypeptides
10/18/2012US20120265158 Transdermal Patch Formulation
10/18/2012US20120265129 Methods for Chronic Pain Management and Treatment using HCG
10/18/2012US20120265119 Transdermal Delivery of Medicinal Cetylated Fatty Esters using Phonophoresis or Iontophoresis
10/18/2012US20120264966 Sulfur-containing phospholipid derivatives
10/18/2012US20120264829 Method for administering an nmda receptor antagonist to a subject
10/18/2012US20120264827 Sulfanylamide derivatives, uses thereof and compositions comprising them
10/18/2012US20120264823 Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
10/18/2012US20120264812 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
10/18/2012US20120264799 Indane-amine derivatives, their preparation and use as medicaments
10/18/2012US20120264798 Prodrugs of inhibitors of plasma kallikrein
10/18/2012US20120264797 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/18/2012US20120264790 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
10/18/2012US20120264784 Methods of treating elevations in mtor signaling
10/18/2012US20120264783 Methods for the treatment of cns-related conditions
10/18/2012US20120264782 Compositions for the treatment of cns-related conditions
10/18/2012US20120264781 Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition